Amrize (NYSE:AMRZ) Price Target Raised to $46.00

Amrize (NYSE:AMRZ – Free Report) had its target price raised by UBS Group from $42.00 to $46.00 in a research report released on Monday morning, Marketbeat Ratings reports. They currently have a hold rating on the stock.

Several other research analysts have also recently issued reports on AMRZ. Wall Street Zen cut Amrize from a “hold” rating to a “sell” rating in a research note on Saturday, November 7th. Weiss Ratings lowered Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. Longbow Research began coverage on Amrize in a research report on Monday, October 12th. They issued a “buy” rating on the stock. Truist Financial cut their price target on shares of Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. Finally, Barclays reduced their price target on shares of Amrize from $55.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, October 19th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and five have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $47.18.

Check Out Our Latest Report on AMRZ

Amrize Price Performance

NYSE AMRZ opened at $40.46 on Monday. The company has a market cap of $22.38 billion, a price-to-earnings ratio of 18.31, a PEG ratio of 1.56 and a beta of 0.04. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The stock’s fifty day moving average price is $39.21 and its 200 day moving average price is $49.79. Amrize has a 1 year low of $35.78 and a 1 year high of $65.94.

Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts’ consensus estimates of $1.05. The company had revenue of $3.77 billion during the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The business’s revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.98 EPS. As a group, equities research analysts forecast that Amrize will post 2.30 earnings per share for the current year.

Amrize Announces Dividend

The company also recently announced a dividend, which was paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th were issued a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, November 10th. Amrize’s payout ratio is 4.98%.

Insiders Place Their Bets

In other news, Director Jacques Sanche bought 4,150 shares of the stock in a transaction dated Wednesday, August 26th. The shares were acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the purchase, the director directly owned 9,766 shares in the company, valued at $439,665.32. The trade was a 73.90% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jan Jenisch bought 26,000 shares of the stock in a transaction dated Wednesday, September 2nd. The shares were purchased at an average cost of $42.47 per share, for a total transaction of $1,104,220.00. Following the completion of the purchase, the chief executive officer owned 1,767,000 shares in the company, valued at approximately $75,044,490. This represents a 1.49% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 34,155 shares of company stock valued at $1,461,276 in the last ninety days. 0.54% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Amrize

Institutional investors and hedge funds have recently modified their holdings of the business. CapitalatWork S.A. acquired a new position in Amrize in the 3rd quarter worth about $38,604,000. Robotti Robert grew its holdings in Amrize by 92.3% in the third quarter. Robotti Robert now owns 37,500 shares of the company’s stock valued at $1,402,000 after purchasing an additional 18,000 shares during the period. Allworth Financial LP acquired a new stake in Amrize in the third quarter valued at approximately $74,000. WCG Wealth Advisors LLC grew its holdings in Amrize by 5.8% in the third quarter. WCG Wealth Advisors LLC now owns 49,046 shares of the company’s stock valued at $1,834,000 after purchasing an additional 2,685 shares during the period. Finally, Credit Industriel ET Commercial increased its position in shares of Amrize by 123.5% in the third quarter. Credit Industriel ET Commercial now owns 2,099 shares of the company’s stock valued at $79,000 after buying an additional 1,160 shares in the last quarter.

About Amrize

(Get Free Report)

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.

Featured Articles

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.